Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Huapont Life Science Co's EBIT per Share for the
three
months ended in Jun. 2026 was ¥0.21.
Its EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2026 was ¥0.67.
During the past 12 months, the average EBIT per Share Growth Rate of Huapont Life Science Co was 26.20% per year.
During the past 3 years, the average EBIT per Share Growth Rate was -9.00% per year.
During the past 5 years, the average EBIT per Share Growth Rate was -3.30% per year.
During the past 10 years, the average EBIT per Share Growth Rate was 6.30% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Huapont Life Science Co's EBIT per Share or its related term are showing as below:
SZSE:002004'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -9 Med: 9.9 Max: 49.3
Current: -9
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Huapont Life Science Co was 49.30% per year. The lowest was -9.00% per year. And the median was 9.90% per year.
SZSE:002004's 3-Year EBIT Growth Rate is ranked worse than 59.62% of 213
companies
in the Agriculture industry
Industry Median: -4.4
vs SZSE:002004: -9.00
Huapont Life Science Co (SZSE:002004) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Huapont Life Science Co EBIT per Share Related Terms
Huapont Life Science Co EBIT per Share Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.67
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Huapont Life Science Co (SZSE:002004) has a EBIT per Share of ¥0.67 as of Jun. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Huapont Life Science Co and its competitors. According to the industry distribution chart, Huapont Life Science Co ranks #127 out of 213 companies in the Agriculture industry, placing it in the top 59.6%.
Is Huapont Life Science Co's EBIT per Share too high?
Huapont Life Science Co's current EBIT per Share is ¥0.67. Based on the distribution chart, Huapont Life Science Co ranks #127 out of 213 companies in the Agriculture industry, which is below the industry midpoint. Overall, Huapont Life Science Co has a GF Score™ of 65/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Huapont Life Science Co's EBIT per Share compare to CTVA and CF?
According to the Agriculture industry distribution chart, Huapont Life Science Co ranks #127 out of 213 companies for EBIT per Share. This places Huapont Life Science Co in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for an Agriculture company?
A good EBIT per Share depends on the Agriculture industry context. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Huapont Life Science Co and its competitors. Huapont Life Science Co's current EBIT per Share is ¥0.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Huapont Life Science Co stock overvalued right now?
Based on GuruFocus' analysis, Huapont Life Science Co (SZSE:002004) is currently considered Fairly Valued. The stock's GF Value™ is ¥4.43, compared to a current price of ¥4.38 — trading 1.1% below its estimated fair value. The current EBIT per Share is ¥0.67. Huapont Life Science Co's overall GF Score™ is 65/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Huapont Life Science Co (SZSE:002004), the current EBIT per Share is ¥0.67 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Huapont Life Science Co (SZSE:002004) Overvalued in 2026?
Based on GuruFocus' analysis, Huapont Life Science Co stock appears to be undervalued.
The current stock price of ¥4.38 is trading 1.1% below its estimated GF Value™ of ¥4.43.
GuruFocus considers Huapont Life Science Co to be Fairly Valued.
Key valuation signals for SZSE:002004:
EBIT per Share: ¥0.67
GF Value™: ¥4.43 vs. price of ¥4.38 (1.1% below fair value)
No single metric tells the full story. See the SZSE:002004 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Huapont Life Science Co Ltd is a China-based company engaged in the manufacturing and distribution of pharmaceutical products. In addition, the company is also engaged in the agrochemical business and medical business. The agrochemical department is mainly engaged in the research and development, production, sales, and technical services of pesticide intermediates, original drugs, and preparations.
65GF Score
Get the complete analysis for SZSE:002004
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SZSE:002004 has been successfully added to your 
